Conference Highlights ASCO

Renal-Cell Carcinoma, Conference Highlights ASCO

Adjuvant Pembrolizumab Therapy Significantly Extends Disease-Free Survival in Patients with Clear-Cell Renal-Cell Carcinoma

Phoebe Starr

Disparities in Cancer Care, Conference Highlights ASCO

ASCO 2021 Presidential Address: Eliminating Disparities in Cancer Care

Wayne Kuznar

Conference Highlights ASCO, Lung Cancer

Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC

Phoebe Starr

Conference Highlights ASCO

Black Patients with Cancer and COVID-19 More Likely Than White Patients to Have Therapy Disruptions

Conference Highlights ASCO

Early Phase 3 Results Show Survival Benefit with Nivolumab-Based Regimens in Advanced Esophageal Squamous-Cell Cancer

Wayne Kuznar

FDA Approvals, Conference Highlights ASCO

FDA Approves Avapritinib for Advanced Systemic Mastocytosis

FDA Approvals, Multiple Myeloma, Conference Highlights ASCO

FDA Approves Darzalex Faspro plus Pomalyst and Dexamethasone for Multiple Myeloma

Multiple Myeloma, Conference Highlights ASCO

New CAR T-Cell Therapy Produces Durable Responses in Relapsed or Refractory Multiple Myeloma

Wayne Kuznar

Melanoma, Conference Highlights ASCO

Novel LAG-3–Blocking Antibody plus Nivolumab Shows Promise as First-Line Treatment in Advanced Melanoma

Wayne Kuznar

FDA Approvals, Urothelial Cancer, Conference Highlights ASCO

Padcev Receives Regular FDA Approval for Locally Advanced or Metastatic Urothelial Cancer

1
2

Page 1 of 2
Results 1 - 10 of 18

SUBSCRIBE

Copyright © Amplity Medical Communications. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.